$OBLG
Oblong, Inc.

2024 Q3 Form 10-Q Financial Statement

#000143774924025172 Filed on August 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $578.0K $611.0K $956.0K
YoY Change -33.72% -36.09% -28.28%
Cost Of Revenue $499.0K $491.0K $834.0K
YoY Change -23.23% -41.13% -9.94%
Gross Profit $79.00K $120.0K $122.0K
YoY Change -64.73% -1.64% -70.02%
Gross Profit Margin 13.67% 19.64% 12.76%
Selling, General & Admin $1.113M $1.073M $1.519M
YoY Change 5.2% -29.36% 1.13%
% of Gross Profit 1408.86% 894.17% 1245.08%
Research & Development $38.00K $65.00K $5.000K
YoY Change 660.0% 1200.0% -98.74%
% of Gross Profit 48.1% 54.17% 4.1%
Depreciation & Amortization $0.00 $0.00 $87.00K
YoY Change -100.0% -100.0% -85.48%
% of Gross Profit 0.0% 0.0% 71.31%
Operating Expenses $1.151M $1.138M $5.000K
YoY Change 8.28% 22660.0% -99.74%
Operating Profit -$1.072M -$1.018M -$1.091M
YoY Change 15.89% -6.69% -87.92%
Interest Expense $32.00K $44.00K -$6.000K
YoY Change -260.0% -833.33%
% of Operating Profit
Other Income/Expense, Net $42.00K
YoY Change
Pretax Income -$1.040M -$974.0K -$1.049M
YoY Change 16.2% -7.15% -88.39%
Income Tax $0.00 $9.000K $0.00
% Of Pretax Income
Net Earnings -$1.040M -$983.0K -$1.049M
YoY Change 16.2% -6.29% -88.39%
Net Earnings / Revenue -179.93% -160.88% -109.73%
Basic Earnings Per Share -$11.25 -$0.04 -$0.78
Diluted Earnings Per Share -$11.25 -$0.04 -$0.78
COMMON SHARES
Basic Shares Outstanding 28.24M 20.29M shares 2.580M shares
Diluted Shares Outstanding 2.487M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.619M $5.858M $6.872M
YoY Change -17.37% -14.76% 34.56%
Cash & Equivalents $5.619M $5.858M $6.872M
Short-Term Investments
Other Short-Term Assets $283.0K $317.0K $836.0K
YoY Change -5.67% -62.08% -27.3%
Inventory $50.00K $88.00K $402.0K
Prepaid Expenses
Receivables $33.00K $31.00K $244.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.985M $6.294M $8.354M
YoY Change -21.01% -24.66% 6.75%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $0.00
YoY Change -100.0%
Goodwill
YoY Change
Intangibles $0.00 $0.00 $432.0K
YoY Change -100.0% -100.0% -93.25%
Long-Term Investments
YoY Change
Other Assets $8.000K $11.00K $22.00K
YoY Change -50.0% -50.0% 0.0%
Total Long-Term Assets $8.000K $11.00K $519.0K
YoY Change -98.01% -97.88% -92.3%
TOTAL ASSETS
Total Short-Term Assets $5.985M $6.294M $8.354M
Total Long-Term Assets $8.000K $11.00K $519.0K
Total Assets $5.993M $6.305M $8.873M
YoY Change -24.89% -28.94% -39.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $93.00K $111.0K $136.0K
YoY Change -12.26% -18.38% -58.15%
Accrued Expenses $1.057M $949.0K $763.0K
YoY Change 8.52% 24.38% -21.82%
Deferred Revenue $52.00K $77.00K $234.0K
YoY Change -66.88% -67.09% -65.89%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.320M $1.247M $1.201M
YoY Change 3.13% 3.83% -49.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.000K $6.000K $57.00K
YoY Change -89.47% -79.72%
Total Long-Term Liabilities $2.000K $6.000K $57.00K
YoY Change -89.47% -79.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.320M $1.247M $1.201M
Total Long-Term Liabilities $2.000K $6.000K $57.00K
Total Liabilities $1.322M $1.253M $1.258M
YoY Change 0.3% -0.4% -52.46%
SHAREHOLDERS EQUITY
Retained Earnings -$231.4M -$230.4M -$226.1M
YoY Change 1.93% 1.87% 4.94%
Common Stock $0.00 $3.000K $233.9M
YoY Change -100.0% -100.0% 2.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.671M $5.052M $7.615M
YoY Change
Total Liabilities & Shareholders Equity $5.993M $6.305M $8.873M
YoY Change -24.89% -28.94% -39.1%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.040M -$983.0K -$1.049M
YoY Change 16.2% -6.29% -88.39%
Depreciation, Depletion And Amortization $0.00 $0.00 $87.00K
YoY Change -100.0% -100.0% -85.48%
Cash From Operating Activities -$911.0K -$1.610M -$1.338M
YoY Change 728.18% 20.33% -11.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 671.0K $1.478M 4.496M
YoY Change -67.13%
NET CHANGE
Cash From Operating Activities -911.0K -$1.610M -1.338M
Cash From Investing Activities 0.000
Cash From Financing Activities 671.0K $1.478M 4.496M
Net Change In Cash -240.0K -$132.0K 3.158M
YoY Change 118.18% -104.18% -313.52%
FREE CASH FLOW
Cash From Operating Activities -$911.0K -$1.610M -$1.338M
Capital Expenditures $0.00
Free Cash Flow -$1.338M
YoY Change -11.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 oblg Preferred Stock Stated Value
PreferredStockStatedValue
545000 usd
CY2023Q4 oblg Preferred Stock Stated Value
PreferredStockStatedValue
545000 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
42000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
42000
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
545
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
545
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1930
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1930
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28249971
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28242418
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16692124
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16684571
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7553
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7553
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28250000
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28242000
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
545
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1930
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35376
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0312442
dei Entity Address Address Line1
EntityAddressAddressLine1
110 16th Street, Suite 1400-1024
dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80202
dei City Area Code
CityAreaCode
213
dei Local Phone Number
LocalPhoneNumber
683-8863 ext. 5
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
OBLG
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28242418
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5858000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5990000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
31000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
424000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
88000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
239000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
317000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
243000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
6294000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6896000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
11000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12000 usd
CY2024Q2 us-gaap Assets
Assets
6305000 usd
CY2023Q4 us-gaap Assets
Assets
6925000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
111000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
211000 usd
CY2024Q2 oblg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1059000 usd
CY2023Q4 oblg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1038000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
77000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
132000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
17000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1247000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1398000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
6000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
26000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1253000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1424000 usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
2000 usd
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
181000 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
181000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
235580000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
233911000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-230350000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-228231000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5052000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5501000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6305000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6925000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
611000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
956000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1237000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1994000 usd
CY2024Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
491000 usd
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
834000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1120000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1596000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
120000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
122000 usd
us-gaap Gross Profit
GrossProfit
117000 usd
us-gaap Gross Profit
GrossProfit
398000 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
65000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
115000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11000 usd
CY2024Q2 oblg Selling And Marketing Expense Income
SellingAndMarketingExpenseIncome
57000 usd
CY2023Q2 oblg Selling And Marketing Expense Income
SellingAndMarketingExpenseIncome
-58000 usd
oblg Selling And Marketing Expense Income
SellingAndMarketingExpenseIncome
111000 usd
oblg Selling And Marketing Expense Income
SellingAndMarketingExpenseIncome
160000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1016000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1577000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2093000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2746000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
87000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
173000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
2000 usd
CY2024Q2 us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
-0 usd
CY2023Q2 us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
400000 usd
us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
-0 usd
us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
400000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1138000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1213000 usd
us-gaap Operating Expenses
OperatingExpenses
2319000 usd
us-gaap Operating Expenses
OperatingExpenses
2692000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1018000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1091000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2202000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2294000 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
44000 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
42000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
92000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
64000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-974000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1049000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2110000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2230000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-983000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1049000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2119000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2268000 usd
CY2024Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
20000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
149000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
64000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
149000 usd
CY2024Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
CY2023Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
25000 usd
CY2024Q2 oblg Warrant Conversions Inducements
WarrantConversionsInducements
0 usd
CY2023Q2 oblg Warrant Conversions Inducements
WarrantConversionsInducements
751000 usd
oblg Warrant Conversions Inducements
WarrantConversionsInducements
0 usd
oblg Warrant Conversions Inducements
WarrantConversionsInducements
751000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1003000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1949000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2183000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3193000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.4
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22882000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20003000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2277000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5501000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1136000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
82000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
44000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4434000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-983000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000 usd
CY2024Q2 oblg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1478000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
112000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
20000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
5052000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
3617000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1219000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
31000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1473000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3902000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1049000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
411000 usd
CY2023Q2 oblg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
534000 usd
CY2023Q2 oblg Adjustments To Additional Paid In Capital Release Of Escrow
AdjustmentsToAdditionalPaidInCapitalReleaseOfEscrow
4000000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
38000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
149000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7615000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2119000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2268000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
173000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-32000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
77000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
62000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
442000 usd
us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
-0 usd
us-gaap Unusual Or Infrequent Item Insurance Proceeds
UnusualOrInfrequentItemInsuranceProceeds
400000 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
2000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-393000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-203000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-151000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-321000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
74000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-213000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-18000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-100000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-48000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
151000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-456000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-75000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-259000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-17000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-168000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1610000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2182000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5435000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1478000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5969000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-132000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3787000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5990000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3085000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5858000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6872000 usd
CY2024Q2 us-gaap Cash
Cash
5358000 usd
CY2023Q2 us-gaap Cash
Cash
6872000 usd
CY2024Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
500000 usd
CY2023Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
0 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5858000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6872000 usd
us-gaap Interest Paid Net
InterestPaidNet
5000 usd
us-gaap Interest Paid Net
InterestPaidNet
9000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
31000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
64000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
149000 usd
oblg Stock Issued Conversion Of Preferred Stock
StockIssuedConversionOfPreferredStock
194000 usd
oblg Stock Issued Conversion Of Preferred Stock
StockIssuedConversionOfPreferredStock
4000 usd
oblg Warrants Modification
WarrantsModification
0 usd
oblg Warrants Modification
WarrantsModification
25000 usd
oblg Warrant Conversions Inducements
WarrantConversionsInducements
0 usd
oblg Warrant Conversions Inducements
WarrantConversionsInducements
751000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5858000 usd
CY2024Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
500000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5990000 usd
CY2023Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
500000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;">Preparation of the Condensed Consolidated Financial Statements in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual amounts could differ from the estimates made. We continually evaluate estimates used in the preparation of our consolidated financial statements for reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based upon such periodic evaluation. The significant areas of estimation include determining the allowances for inventory obsolescence and estimated credit losses and the inputs used in the fair value of equity-based awards.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:18pt;"></p>
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
87000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
173000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
17000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
17000 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
36000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
82000 usd
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
11000 usd
us-gaap Sublease Income
SubleaseIncome
27000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5858000 usd
CY2024Q2 oblg Working Capital
WorkingCapital
5047000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2119000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1478000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1610000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
675000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
448000 usd
CY2024Q2 us-gaap Deposit Liability Current
DepositLiabilityCurrent
86000 usd
CY2023Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
118000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
93000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
104000 usd
CY2024Q2 oblg Accrued Taxes And Regulatory Fees Current
AccruedTaxesAndRegulatoryFeesCurrent
20000 usd
CY2023Q4 oblg Accrued Taxes And Regulatory Fees Current
AccruedTaxesAndRegulatoryFeesCurrent
22000 usd
CY2024Q2 us-gaap Accrued Rent Current
AccruedRentCurrent
170000 usd
CY2023Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
202000 usd
CY2024Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
4000 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
136000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8000 usd
CY2024Q2 oblg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1059000 usd
CY2023Q4 oblg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1038000 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5101345
CY2024Q2 oblg Preferred Stock Shares Designated
PreferredStockSharesDesignated
1983250
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
545
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1930
CY2023Q4 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.2792
CY2023Q4 us-gaap Preferred Stock Convertible Conversion Price
PreferredStockConvertibleConversionPrice
0.2792
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16668
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
143.62
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
239.38
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
-0
CY2023 oblg Sharebased Compensation Arrangements By Sharebased Payment Award Options Vested In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
0
CY2023 oblg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableVestedNumberOfShares
3336
CY2023 oblg Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Vested In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableVestedInPeriodWeightedAverageExercisePrice
48.75
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6668
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
285.89
CY2023 oblg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Expirations In Period Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableExpirationsInPeriodNumberOfShares
6668
CY2023 oblg Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Exercises In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableExercisesInPeriodWeightedAverageExercisePrice
285.89
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.75
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6668
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
48.75
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
-0
oblg Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableVestedNumberOfShares
3332
oblg Sharebased Compensation Arrangements By Sharebased Payment Award Options Exercisable Vested In Period Weighted Average Exercise Price
SharebasedCompensationArrangementsBySharebasedPaymentAwardOptionsExercisableVestedInPeriodWeightedAverageExercisePrice
48.75
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.75
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
10000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
48.75
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-983000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1049000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2119000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2268000 usd
CY2024Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
20000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
149000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
64000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
149000 usd
CY2024Q2 oblg Warrant Conversions Inducements
WarrantConversionsInducements
0 usd
CY2023Q2 oblg Warrant Conversions Inducements
WarrantConversionsInducements
751000 usd
oblg Warrant Conversions Inducements
WarrantConversionsInducements
0 usd
oblg Warrant Conversions Inducements
WarrantConversionsInducements
751000 usd
CY2024Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
CY2023Q2 us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
0 usd
us-gaap Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount
25000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1003000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1949000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2183000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3193000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22882000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20003000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2277000
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.4
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
611000 usd
CY2024Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
491000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
120000 usd
CY2024Q2 oblg Gross Profit Percentage
GrossProfitPercentage
0.20 pure
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
1138000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1018000 usd
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
44000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-974000 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-983000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
956000 usd
CY2023Q2 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
834000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
122000 usd
CY2023Q2 oblg Gross Profit Percentage
GrossProfitPercentage
0.13 pure
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1213000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1091000 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
42000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1049000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1049000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1237000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1120000 usd
us-gaap Gross Profit
GrossProfit
117000 usd
oblg Gross Profit Percentage
GrossProfitPercentage
0.09 pure
us-gaap Operating Expenses
OperatingExpenses
2319000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2202000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
92000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2110000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2119000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1994000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1596000 usd
us-gaap Gross Profit
GrossProfit
398000 usd
oblg Gross Profit Percentage
GrossProfitPercentage
0.20 pure
us-gaap Operating Expenses
OperatingExpenses
2692000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2294000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
64000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2230000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2268000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
611000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
956000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1237000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1994000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
611000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
956000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1237000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1994000 usd

Files In Submission

Name View Source Status
0001437749-24-025172-index-headers.html Edgar Link pending
0001437749-24-025172-index.html Edgar Link pending
0001437749-24-025172.txt Edgar Link pending
0001437749-24-025172-xbrl.zip Edgar Link pending
ex_670943.htm Edgar Link pending
ex_670944.htm Edgar Link pending
ex_670945.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
oblg-20240630.xsd Edgar Link pending
oblg20240630_10q.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
oblg-20240630_cal.xml Edgar Link unprocessable
oblg-20240630_def.xml Edgar Link unprocessable
oblg-20240630_lab.xml Edgar Link unprocessable
oblg-20240630_pre.xml Edgar Link unprocessable
oblg20240630_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending